From Cystic Fibrosis Foundation <[email protected]>
Subject Do you have questions about CF research and care?
Date April 1, 2024 8:06 PM
  Links have been removed from this email. Learn more in the FAQ.
  Links have been removed from this email. Learn more in the FAQ.
ResearchCon is April 30-May 1


([link removed])


You're invited!
Join the cystic fibrosis community at ResearchCon April 30-May 1 ([link removed]).


I ([link removed])


Regardless of your connection to CF, you can discuss the latest in CF-related science, research, clinical care, and lived experience alongside others living with and studying the disease at ResearchCon.

### During this exciting two-day, virtual event, you will:

* Discuss the work being done for people living without modulators, evolving infection research, the coordination of transplant and CF care, and more
* Get a sneak peek into the work being done at the CF Foundation Therapeutics Lab
* Ask your questions and gain valuable knowledge to help you be a better advocate
* Understand how clinical trials work and what it looks like to participate in one
* Participate in roundtable discussions with CF researchers and clinicians
* Connect with others in the CF community through social chats



REGISTER NOW ([link removed])


All keynotes and topic-based sessions will offer high-accuracy closed captioning and live audio Spanish translation. Can't join us live?
Register today to receive recordings from ResearchCon after the event ([link removed]).



HELP US MAKE CF STAND FOR CURE FOUND


DONATE ([link removed])


([link removed])
% link:[link removed] name="[link removed]" content="" %]
% link:[link removed] name="[link removed]" content="" %]
% link:[link removed] name="[link removed]" content="" %]
% link:[link removed] name="[link removed]" content="" %]


4550 Montgomery Avenue, Suite 1100N | Bethesda, MD 20814 US

Got this as a forward? [Sign up]([link removed]) to receive our future emails.

[Opt out]([link removed]) of this mailing list |
Opt out ([link removed])
of all CFF emails

This email was sent to [email protected].
To continue receiving our emails, add us to your address book.
Screenshot of the email generated on import

Message Analysis